contract_awardAwarded Tuesday, May 5, 2026Analyzed

BELLESE TECHNOLOGIES, LLC: $25.8M Department of Health and Human Services Contract

Neutral

Summary

This $25.8M contract to private firm Bellese Technologies for CMS hospital quality reporting is a sector signal for healthcare IT spending, but no publicly traded company is directly tied. The award aligns with healthcare transparency bills like HR8324, but lacks a public beneficiary.

See which stocks are affected

Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.

Already have an account? Log in

Key Takeaways

  • 1.Bellese Technologies is private; no public ticker exposure.
  • 2.Contract is a routine bridge renewal for hospital quality reporting.
  • 3.Healthcare IT sector remains stable but no catalyst from this award.

Market Implications

This contract does not directly affect any publicly traded company, so market implications are minimal. The healthcare IT sector may see indirect benefits from sustained government spending on quality reporting, but without a public recipient, no stock movement is expected. Investors should monitor future awards to public firms like Cerner (now Oracle Health) or Epic Systems (private) for clearer signals.

Full Analysis

The Centers for Medicare and Medicaid Services awarded Bellese Technologies, LLC a $25.8M delivery order for the Hospital Quality Reporting (HQR) II Bridge contract, covering a one-year period from May 2026 to May 2027. Bellese Technologies is a private entity with no publicly traded parent or recognized subsidiary, so no direct stock impact can be attributed. The contract supports CMS's ongoing efforts to collect and report hospital quality data, a function critical to value-based care initiatives. In the healthcare IT sector, this award signals continued federal investment in quality measurement infrastructure, which benefits private firms like Bellese and potentially subcontractors, but no public tickers are identifiable from available data. Related legislation such as HR8324 (Great American Healthcare Plan) and HR8857 (adjusting drug price negotiation) indicate a bullish legislative environment for healthcare transparency, but this specific contract is a routine bridge renewal rather than a transformative award. Without a public company recipient, supply chain beneficiaries cannot be reliably identified, and historical patterns for private-entity contracts show no direct market movement. The neutral sentiment reflects the lack of a public equity link, though the contract reinforces steady demand for healthcare data services.

Related Presidential Actions

Executive orders & memoranda affecting the same sectors or companies

proclamationAug 13, 2026

Adjusting Imports of Unmanned Aircraft Systems and Unmanned Aircraft Systems Components into the United States

This proclamation imposes a 100% ad valorem tariff on imports of unmanned aircraft systems (UAS) over 25 kg, those with thermal imagers, docking stations, and certain components, and a 25% tariff on UAS under 25 kg and other components, citing national security under Section 232 of the Trade Expansion Act. It also authorizes the Department of Commerce to establish an onshoring program offering preferential tariff treatment for companies that build new U.S. manufacturing facilities for UAS and components.

presidential_memorandumAug 12, 2026

Expanding Capabilities to Combat Transnational Cyber-Enabled Crime

This memorandum establishes a government program, managed by the National Coordination Center (NCC), that authorizes private companies to conduct cyber surveillance and operations against foreign cyber-enabled transnational criminal organizations under federal oversight. It directs the Department of Justice and Department of Homeland Security to co-execute the program, requiring vetted companies to enter contracts with the government and potentially post a $1 million bond, with implementation guidance to be developed within 60 days.

Exec OrderAug 10, 2026

Delivering Gold Standard Childhood Vaccine Recommendations for Americans

This executive order directs HHS to establish a 'Gold Standard' childhood vaccine schedule with fewer recommended vaccines than current CDC guidelines, mandates that MMR be administered as three separate single-disease shots when domestically available, and instructs the DOJ to challenge state vaccine mandates that do not provide religious or medical exemptions. It also orders HHS to develop alternative adjuvants to aluminum and improve vaccine safety monitoring, while preserving access to existing vaccines.

Contract Details

Recipient

BELLESE TECHNOLOGIES, LLC

Award Amount

$25,772,226

Awarding Agency

Department of Health and Human Services

Sub-Agency

Centers for Medicare and Medicaid Services

Contract Type

DELIVERY ORDER

Related Bills

HR8324HR8857

Free — no credit card

Get the next market-moving signal before the news does

HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.

Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.

Free forever plan · No credit card · Unsubscribe in one click

Want the live terminal too? Create a free account →